Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
for
Pleural Neoplasm
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT03465774
Recruiting
Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell
for
Cell Therapy
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06575374
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT02918474
Recruiting
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
for
Stage III Thymoma AJCC v8, Stage IIIA Thymoma AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT03295227
Phase 1, Recruiting
Role of Diet on the Microbiome of the Digestive System
for
Colorectal Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 45+
Code: NCT04666727
Recruiting
Feasibility of Accelerated, Personalized rTMS as an Adjuvant for Impulse Control Disorders: a Pilot Study
for
Impulse Control Disorder
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 21 - 60
Code: NCT06639594
Phase 1, Recruiting
Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides
for
Mycosis Fungoides
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05357794
Phase 2, Recruiting
Psychophysical Studies of Cancer Therapy Pain
for
Advanced Cancer, Pain
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT00515060
Recruiting
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
for
Breast Carcinoma, Esophageal Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT00991094
Recruiting
Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
for
Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05733091
Recruiting
Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients
for
Mantle Cell Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06263491
Phase 2, Recruiting
Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)
for
Mesonephric-like Adenocarcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06377527
Recruiting
Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
for
Cancer, Head and Neck Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06667427
Recruiting
A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias
for
Refractory Acute Leukemia, Pediatric Relapsed
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 2 - 21
Code: NCT06397027
Phase 1, Recruiting
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
for
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05092373
Phase 1, Recruiting
Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma
for
Sinonasal Melanoma, Anorectal Melanoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05546827
Phase 2, Recruiting
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)